CRISPR/Cas9 genome editing system and its application in tumor therapy

Abstract

Yang Yehuan, Yang Chengwei, Tan Xiaoqing, Gao Xingchun. CRISPR/Cas9 genome editing system and its application in tumor therapy[J]. Journal of International Oncology, 2018, 45(8): 556-560.

［1］ Ul Ain Q, Chung JY, Kim YH. Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN［J］. J Control Release, 2015, 205: 120127. DOI: 10.1016/j.jconrel.2014.12.036. ［2］ Mojica FJ, DiezVillasenor C, Soria E, et al. Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondria［J］. Mol Microbiol, 2000, 36(1): 244246. ［3］ Barrangou R, Fremaux C, Deveau H, et al. CRISPR provides acquired resistance against viruses in prokaryotes［J］. Science, 2007, 315(5819): 17091712. DOI: 10.1126/science.1138140. ［4］ Mojica FJ, DiezVillasenor C, GarciaMartinez J, et al. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements［J］. J Mol Evol, 2005, 60(2): 174182. DOI: 10.1007/s0023900400463. ［5］ Brouns SJ, Jore MM, Lundgren M, et al. Small CRISPR RNAs guide antiviral defense in prokaryotes［J］. Science, 2008, 321(5891): 960964. DOI: 10.1126/science.1159689. ［6］ Marraffini LA, Sontheimer EJ. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA［J］. Science, 2008, 322(5909): 18431845. DOI: 10.1126/science.1165771. ［7］ Deveau H, Barrangou R, Garneau JE, et al. Phage response to CRISPRencoded resistance in Streptococcus thermophilus［J］. J Bacteriol, 2008, 190(4): 13901400. DOI: 10.1128/JB.0141207. ［8］ Shen J, Lv L, Wang X, et al. Comparative analysis of CRISPRCas systems in Klebsiella genomes［J］. J Basic Microbiol, 2017, 57(4): 325336. DOI: 10.1002/jobm.201600589. ［9］ Guan L, Han Y, Zhu S, et al. Application of CRISPRCas system in gene therapy: preclinical progress in animal model［J］. DNA Repair (Amst), 2016, 46: 18. DOI: 10.1016/j.dnarep.2016.07.004. ［10］ Makarova KS, Wolf YI, Alkhnbashi OS, et al. An updated evolutionary classification of CRISPRCas systems［J］. Nat Rev Microbiol, 2015, 13(11): 722736. DOI: 10.1038/nrmicro3569. ［11］杨帆, 李寅. 新一代基因组编辑系统CRISPR/Cpf1［J］. 生物工程学报, 2017, 33(3): 361371. DOI: 10.13345/j.cjb.170029. ［12］ Kunin V, Sorek R, Hugenholtz P. Evolutionary conservation of sequence and secondary structures in CRISPR repeats［J］. Genome Biol, 2007, 8(4): R61. DOI: 10.1186/gb200784r61. ［13］ Barrangou R, Fremaux C, Deveau H, et al. CRISPR provides acquired resistance against viruses in prokaryotes［J］. Science, 2007, 315(5819): 17091712. DOI: 10.1126/science.1138140. ［14］杨悦, 訾晓渊, 孙颖浩. CRISPRCas基因编辑技术在泌尿系统肿瘤研究中的应用［J］. 中国肿瘤生物治疗杂志, 2018, 25(1): 916. DOI: 10.3872/j.issn.1007385X.2018.01.002. ［15］ Li Y, Ma S, Sun L, et al. Programmable single and multiplex baseediting in bombyx mori using RNAguided cytidine deaminases［J］. G3 (Bethesda), 2018, 8(5): 17011709. DOI: 10.1534/g3.118.200134. ［16］ White MK, Khalili K. CRISPR/Cas9 and cancer targets: future possibilities and present challenges［J］. Oncotarget, 2016, 7(11): 1230512317. DOI: 10.18632/oncotarget.7104. ［17］孟泽松, 王飞飞, 王光林, 等. CRISPR/Cas9基因编辑技术在肿瘤研究及治疗中的应用［J］. 肿瘤, 2016, 36(5): 13951401. DOI: 10.3781/j.issn.10007431.2016.55.514. ［18］ Hu Z, Yu L, Zhu D, et al. Disruption of HPV16E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells［J］. Biomed Res Int, 2014, 2014: 612823. DOI: 10.1155/2014/612823. ［19］ Zhen S, Li X. Oncogenic human papillomavirus: application of CRISPR/Cas9 therapeutic strategies for cervical cancer［J］. Cell Physiol Biochem, 2017, 44(6): 24552466. DOI: 10.1159/000486168. ［20］ Noguchi T, Ward JP, Gubin MM, et al. Temporally distinct PDL1 expression by tumor and host cells contributes to immune escape［J］. Cancer Immunol Res, 2017, 5(2): 106117. DOI: 10.1158/23266066.CIR160391. ［21］ Su S, Hu B, Shao J, et al. CRISPRCas9 mediated efficient PD1 disruption on human primary T cells from cancer patients［J］. Sci Rep, 2016, 6: 20070. DOI: 10.1038/srep20070. ［22］ Kalebic N, Taverna E, Tavano S, et al. CRISPR/Cas9induced disruption of gene expression in mouse embryonic brain and single neural stem cells in vivo［J］. EMBO Rep, 2016, 17(3): 338348. DOI: 10.15252/embr.201541715. ［23］ Li L, Hu S, Chen X. Nonviral delivery systems for CRISPR/Cas9based genome editing: challenges and opportunities［J］. Biomaterials, 2018, 171: 207218. DOI: 10.1016/j.biomaterials.2018.04.031. ［24］ Kulcsár PI, Tálas A, Huszár K, et al. Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage［J］. Genome Biol, 2017, 18(1): 190. DOI: 10.1186/s1305901713188. ［25］ Chen JS, Dagdas YS, Kleinstiver BP, et al. Enhanced proofreading governs CRISPRCas9 targeting accuracy［J］. Nature, 2017, 550(7676): 407410. DOI: 10.1038/nature24268. ［26］ Cox DBT, Gootenberg JS, Abudayyeh OO, et al. RNA editing with CRISPRCas13［J］. Science, 2017, 358(6366): 10191027. DOI: 10.1126/science.aaq0180.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

CRISPR/Cas9 genome editing system and its application in tumor therapy

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments